These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate. Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408 [No Abstract] [Full Text] [Related]
43. Atherosclerosis as a pediatric problem. Wells CR Del Med J; 1974 Sep; 46(9):457-63. PubMed ID: 4369794 [No Abstract] [Full Text] [Related]
44. [Relations between primary hyperlipoproteinemia and cardiovascular diseases from geriatric aspects]. Reuter W Z Arztl Fortbild (Jena); 1977 Jan; 71(2):62-5. PubMed ID: 848050 [No Abstract] [Full Text] [Related]
46. [Etiology and pathogenesis of arteriosclerosis]. Schettler G; Mörl H Naturwissenschaften; 1978 Mar; 65(3):130-6. PubMed ID: 205805 [TBL] [Abstract][Full Text] [Related]
47. [Clinical study on the relationship between diabetes, hyperlipoproteinemia and atheromatosis]. Righetti A; Scherrer JR; Micheli H; Pometta D Schweiz Med Wochenschr; 1973 May; 103(18):668-73. PubMed ID: 4702987 [No Abstract] [Full Text] [Related]
48. [Hyperlipoproteinema in chronic arteriosclerotic vascular diseases with occlusions of lower extremities (author's transl)]. Müller G Angiologica; 1973; 10(5-6):318-25. PubMed ID: 4360828 [No Abstract] [Full Text] [Related]
49. Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Heinle RA; Levy RI; Frederickson DS; Gorlin R Am J Cardiol; 1969 Aug; 24(2):178-86. PubMed ID: 5799079 [No Abstract] [Full Text] [Related]
50. Can modification of risk factors reduce coronary heart disease? Grundy SM Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670 [No Abstract] [Full Text] [Related]
51. The in vivo oxidized LDL to LDL-cholesterol ratio is correlated with lipid content of LDL. Junjun W; Yiyi Z; Xiaozhuan L; Daning C Atherosclerosis; 2000 Mar; 149(1):217-8. PubMed ID: 10799013 [No Abstract] [Full Text] [Related]
53. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
54. Evaluation of rapid screening methods for the detection of abnormal lipid states related to atherosclerosis. Boyle E; Dash HH; Owen D; Yarmosh D Ann Clin Lab Sci (1971); 1972; 2(5):393-403. PubMed ID: 4343280 [No Abstract] [Full Text] [Related]
55. Coronary artery disease in young women. Engel HJ; Page HL; Campbell WB JAMA; 1974 Dec; 230(11):1531-4. PubMed ID: 4479662 [No Abstract] [Full Text] [Related]
56. [Hyperlipoproteinemia and its role in the pathogenesis of arteriosclerosis]. Klimov AN Patol Fiziol Eksp Ter; 1972; 16(5):3-12. PubMed ID: 4363573 [No Abstract] [Full Text] [Related]